Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

MOPP regimen

View Patient Information

A chemotherapy regimen consisting of mechlorethamine, vincristine (Oncovin), procarbazine and prednisone, used alone or in combination with radiation therapy for the treatment of stage I-IV Hodgkin lymphoma. Due to the increased risk of gonadal toxicity, this regimen has been widely replaced by the ABVD regimen.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	mechlorethamine/prednisone/procarbazine/vincristine regimen Mustargen-Oncovin-procarbazine-prednisone regimen
Acronym:	MOPP

MOPP regimen

Search NCI's Drug Dictionary